Fourth, inclusion of some subjects who had started to take medications, such as hypoglycemic medications, insulin, antihypertensive medications, or lipid-lowering medications, during the follow-up period may have contributed to an underestimation of the association between metabolically healthy obesity and proteinuria. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.